TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Rosuvastatin Drugs Market Insights, Forecast to 2028

Global Rosuvastatin Drugs Market Insights, Forecast to 2028

  • Category:Life Sciences
  • Published on : 08 September 2022
  • Pages :77
  • Formats:
  • Report Code:SMR-7337479
OfferClick for best price

Best Price: $3920

Rosuvastatin Drugs Market Size, Share 2022


Market Analysis and Insights: Global Rosuvastatin Drugs Market

The global Rosuvastatin Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Rosuvastatin Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Rosuvastatin Drugs market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Rosuvastatin Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Rosuvastatin Drugs market.

Global Rosuvastatin Drugs Scope and Market Size

Rosuvastatin Drugs market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Rosuvastatin Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

5 mg Tablet

10 mg Tablet

20 mg Tablet

40 mg Tablet

Segment by Application

Hyperlipidemia And Mixed Dyslipidemia

Familial Hypercholesterolemia

Hypertriglyceridemia

Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)

Atherosclerosis

Others

By Company

AstraZeneca

Watson

ANGITA

Sun Pharmaceutical Industries

By Region

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Rosuvastatin Drugs product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Rosuvastatin Drugs, with price, sales, revenue, and global market share of Rosuvastatin Drugs from 2019 to 2022.

Chapter 3, the Rosuvastatin Drugs competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Rosuvastatin Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Rosuvastatin Drugs market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Rosuvastatin Drugs.

Chapter 13, 14, and 15, to describe Rosuvastatin Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Rosuvastatin Drugs Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Rosuvastatin Drugs Market Insights, Forecast to 2028
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 77 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Study Coverage
1.1 Rosuvastatin Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Rosuvastatin Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 5 mg Tablet
1.2.3 10 mg Tablet
1.2.4 20 mg Tablet
1.2.5 40 mg Tablet
1.3 Market by Application
1.3.1 Global Rosuvastatin Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hyperlipidemia And Mixed Dyslipidemia
1.3.3 Familial Hypercholesterolemia
1.3.4 Hypertriglyceridemia
1.3.5 Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
1.3.6 Atherosclerosis
1.3.7 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Rosuvastatin Drugs Sales Estimates and Forecasts 2017-2028
2.2 Global Rosuvastatin Drugs Revenue Estimates and Forecasts 2017-2028
2.3 Global Rosuvastatin Drugs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Rosuvastatin Drugs Sales by Region
2.4.1 Global Rosuvastatin Drugs Sales by Region (2017-2022)
2.4.2 Global Sales Rosuvastatin Drugs by Region (2023-2028)
2.5 Global Rosuvastatin Drugs Revenue by Region
2.5.1 Global Rosuvastatin Drugs Revenue by Region (2017-2022)
2.5.2 Global Rosuvastatin Drugs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Rosuvastatin Drugs Sales by Manufacturers
3.1.1 Global Top Rosuvastatin Drugs Manufacturers by Sales (2017-2022)
3.1.2 Global Rosuvastatin Drugs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Rosuvastatin Drugs in 2021
3.2 Global Rosuvastatin Drugs Revenue by Manufacturers
3.2.1 Global Rosuvastatin Drugs Revenue by Manufacturers (2017-2022)
3.2.2 Global Rosuvastatin Drugs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Rosuvastatin Drugs Revenue in 2021
3.3 Global Rosuvastatin Drugs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Rosuvastatin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Rosuvastatin Drugs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Rosuvastatin Drugs Sales by Type
4.1.1 Global Rosuvastatin Drugs Historical Sales by Type (2017-2022)
4.1.2 Global Rosuvastatin Drugs Forecasted Sales by Type (2023-2028)
4.1.3 Global Rosuvastatin Drugs Sales Market Share by Type (2017-2028)
4.2 Global Rosuvastatin Drugs Revenue by Type
4.2.1 Global Rosuvastatin Drugs Historical Revenue by Type (2017-2022)
4.2.2 Global Rosuvastatin Drugs Forecasted Revenue by Type (2023-2028)
4.2.3 Global Rosuvastatin Drugs Revenue Market Share by Type (2017-2028)
4.3 Global Rosuvastatin Drugs Price by Type
4.3.1 Global Rosuvastatin Drugs Price by Type (2017-2022)
4.3.2 Global Rosuvastatin Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Rosuvastatin Drugs Sales by Application
5.1.1 Global Rosuvastatin Drugs Historical Sales by Application (2017-2022)
5.1.2 Global Rosuvastatin Drugs Forecasted Sales by Application (2023-2028)
5.1.3 Global Rosuvastatin Drugs Sales Market Share by Application (2017-2028)
5.2 Global Rosuvastatin Drugs Revenue by Application
5.2.1 Global Rosuvastatin Drugs Historical Revenue by Application (2017-2022)
5.2.2 Global Rosuvastatin Drugs Forecasted Revenue by Application (2023-2028)
5.2.3 Global Rosuvastatin Drugs Revenue Market Share by Application (2017-2028)
5.3 Global Rosuvastatin Drugs Price by Application
5.3.1 Global Rosuvastatin Drugs Price by Application (2017-2022)
5.3.2 Global Rosuvastatin Drugs Price Forecast by Application (2023-2028)
6 North America
6.1 North America Rosuvastatin Drugs Market Size by Type
6.1.1 North America Rosuvastatin Drugs Sales by Type (2017-2028)
6.1.2 North America Rosuvastatin Drugs Revenue by Type (2017-2028)
6.2 North America Rosuvastatin Drugs Market Size by Application
6.2.1 North America Rosuvastatin Drugs Sales by Application (2017-2028)
6.2.2 North America Rosuvastatin Drugs Revenue by Application (2017-2028)
6.3 North America Rosuvastatin Drugs Market Size by Country
6.3.1 North America Rosuvastatin Drugs Sales by Country (2017-2028)
6.3.2 North America Rosuvastatin Drugs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Rosuvastatin Drugs Market Size by Type
7.1.1 Europe Rosuvastatin Drugs Sales by Type (2017-2028)
7.1.2 Europe Rosuvastatin Drugs Revenue by Type (2017-2028)
7.2 Europe Rosuvastatin Drugs Market Size by Application
7.2.1 Europe Rosuvastatin Drugs Sales by Application (2017-2028)
7.2.2 Europe Rosuvastatin Drugs Revenue by Application (2017-2028)
7.3 Europe Rosuvastatin Drugs Market Size by Country
7.3.1 Europe Rosuvastatin Drugs Sales by Country (2017-2028)
7.3.2 Europe Rosuvastatin Drugs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Rosuvastatin Drugs Market Size by Type
8.1.1 Asia Pacific Rosuvastatin Drugs Sales by Type (2017-2028)
8.1.2 Asia Pacific Rosuvastatin Drugs Revenue by Type (2017-2028)
8.2 Asia Pacific Rosuvastatin Drugs Market Size by Application
8.2.1 Asia Pacific Rosuvastatin Drugs Sales by Application (2017-2028)
8.2.2 Asia Pacific Rosuvastatin Drugs Revenue by Application (2017-2028)
8.3 Asia Pacific Rosuvastatin Drugs Market Size by Region
8.3.1 Asia Pacific Rosuvastatin Drugs Sales by Region (2017-2028)
8.3.2 Asia Pacific Rosuvastatin Drugs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Rosuvastatin Drugs Market Size by Type
9.1.1 Latin America Rosuvastatin Drugs Sales by Type (2017-2028)
9.1.2 Latin America Rosuvastatin Drugs Revenue by Type (2017-2028)
9.2 Latin America Rosuvastatin Drugs Market Size by Application
9.2.1 Latin America Rosuvastatin Drugs Sales by Application (2017-2028)
9.2.2 Latin America Rosuvastatin Drugs Revenue by Application (2017-2028)
9.3 Latin America Rosuvastatin Drugs Market Size by Country
9.3.1 Latin America Rosuvastatin Drugs Sales by Country (2017-2028)
9.3.2 Latin America Rosuvastatin Drugs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Rosuvastatin Drugs Market Size by Type
10.1.1 Middle East and Africa Rosuvastatin Drugs Sales by Type (2017-2028)
10.1.2 Middle East and Africa Rosuvastatin Drugs Revenue by Type (2017-2028)
10.2 Middle East and Africa Rosuvastatin Drugs Market Size by Application
10.2.1 Middle East and Africa Rosuvastatin Drugs Sales by Application (2017-2028)
10.2.2 Middle East and Africa Rosuvastatin Drugs Revenue by Application (2017-2028)
10.3 Middle East and Africa Rosuvastatin Drugs Market Size by Country
10.3.1 Middle East and Africa Rosuvastatin Drugs Sales by Country (2017-2028)
10.3.2 Middle East and Africa Rosuvastatin Drugs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Corporation Information
11.1.2 AstraZeneca Overview
11.1.3 AstraZeneca Rosuvastatin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 AstraZeneca Rosuvastatin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 AstraZeneca Recent Developments
11.2 Watson
11.2.1 Watson Corporation Information
11.2.2 Watson Overview
11.2.3 Watson Rosuvastatin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Watson Rosuvastatin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Watson Recent Developments
11.3 ANGITA
11.3.1 ANGITA Corporation Information
11.3.2 ANGITA Overview
11.3.3 ANGITA Rosuvastatin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 ANGITA Rosuvastatin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 ANGITA Recent Developments
11.4 Sun Pharmaceutical Industries
11.4.1 Sun Pharmaceutical Industries Corporation Information
11.4.2 Sun Pharmaceutical Industries Overview
11.4.3 Sun Pharmaceutical Industries Rosuvastatin Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sun Pharmaceutical Industries Rosuvastatin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharmaceutical Industries Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Rosuvastatin Drugs Industry Chain Analysis
12.2 Rosuvastatin Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Rosuvastatin Drugs Production Mode & Process
12.4 Rosuvastatin Drugs Sales and Marketing
12.4.1 Rosuvastatin Drugs Sales Channels
12.4.2 Rosuvastatin Drugs Distributors
12.5 Rosuvastatin Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Rosuvastatin Drugs Industry Trends
13.2 Rosuvastatin Drugs Market Drivers
13.3 Rosuvastatin Drugs Market Challenges
13.4 Rosuvastatin Drugs Market Restraints
14 Key Findings in The Global Rosuvastatin Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Rosuvastatin Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 5 mg Tablet
Table 3. Major Manufacturers of 10 mg Tablet
Table 4. Major Manufacturers of 20 mg Tablet
Table 5. Major Manufacturers of 40 mg Tablet
Table 6. Global Rosuvastatin Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Rosuvastatin Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Rosuvastatin Drugs Sales by Region (2017-2022) & (K Units)
Table 9. Global Rosuvastatin Drugs Sales Market Share by Region (2017-2022)
Table 10. Global Rosuvastatin Drugs Sales by Region (2023-2028) & (K Units)
Table 11. Global Rosuvastatin Drugs Sales Market Share by Region (2023-2028)
Table 12. Global Rosuvastatin Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Rosuvastatin Drugs Revenue Market Share by Region (2017-2022)
Table 14. Global Rosuvastatin Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Rosuvastatin Drugs Revenue Market Share by Region (2023-2028)
Table 16. Global Rosuvastatin Drugs Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Rosuvastatin Drugs Sales Share by Manufacturers (2017-2022)
Table 18. Global Rosuvastatin Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Rosuvastatin Drugs Revenue Share by Manufacturers (2017-2022)
Table 20. Rosuvastatin Drugs Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Rosuvastatin Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Rosuvastatin Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rosuvastatin Drugs as of 2021)
Table 23. Rosuvastatin Drugs Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Rosuvastatin Drugs Product Offered
Table 25. Date of Manufacturers Enter into Rosuvastatin Drugs Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Rosuvastatin Drugs Sales by Type (2017-2022) & (K Units)
Table 28. Global Rosuvastatin Drugs Sales by Type (2023-2028) & (K Units)
Table 29. Global Rosuvastatin Drugs Sales Share by Type (2017-2022)
Table 30. Global Rosuvastatin Drugs Sales Share by Type (2023-2028)
Table 31. Global Rosuvastatin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Rosuvastatin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Rosuvastatin Drugs Revenue Share by Type (2017-2022)
Table 34. Global Rosuvastatin Drugs Revenue Share by Type (2023-2028)
Table 35. Rosuvastatin Drugs Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Rosuvastatin Drugs Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Rosuvastatin Drugs Sales by Application (2017-2022) & (K Units)
Table 38. Global Rosuvastatin Drugs Sales by Application (2023-2028) & (K Units)
Table 39. Global Rosuvastatin Drugs Sales Share by Application (2017-2022)
Table 40. Global Rosuvastatin Drugs Sales Share by Application (2023-2028)
Table 41. Global Rosuvastatin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Rosuvastatin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Rosuvastatin Drugs Revenue Share by Application (2017-2022)
Table 44. Global Rosuvastatin Drugs Revenue Share by Application (2023-2028)
Table 45. Rosuvastatin Drugs Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Rosuvastatin Drugs Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Rosuvastatin Drugs Sales by Type (2017-2022) & (K Units)
Table 48. North America Rosuvastatin Drugs Sales by Type (2023-2028) & (K Units)
Table 49. North America Rosuvastatin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Rosuvastatin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Rosuvastatin Drugs Sales by Application (2017-2022) & (K Units)
Table 52. North America Rosuvastatin Drugs Sales by Application (2023-2028) & (K Units)
Table 53. North America Rosuvastatin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Rosuvastatin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Rosuvastatin Drugs Sales by Country (2017-2022) & (K Units)
Table 56. North America Rosuvastatin Drugs Sales by Country (2023-2028) & (K Units)
Table 57. North America Rosuvastatin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Rosuvastatin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Rosuvastatin Drugs Sales by Type (2017-2022) & (K Units)
Table 60. Europe Rosuvastatin Drugs Sales by Type (2023-2028) & (K Units)
Table 61. Europe Rosuvastatin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Rosuvastatin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Rosuvastatin Drugs Sales by Application (2017-2022) & (K Units)
Table 64. Europe Rosuvastatin Drugs Sales by Application (2023-2028) & (K Units)
Table 65. Europe Rosuvastatin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Rosuvastatin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Rosuvastatin Drugs Sales by Country (2017-2022) & (K Units)
Table 68. Europe Rosuvastatin Drugs Sales by Country (2023-2028) & (K Units)
Table 69. Europe Rosuvastatin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Rosuvastatin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Rosuvastatin Drugs Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Rosuvastatin Drugs Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Rosuvastatin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Rosuvastatin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Rosuvastatin Drugs Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Rosuvastatin Drugs Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Rosuvastatin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Rosuvastatin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Rosuvastatin Drugs Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Rosuvastatin Drugs Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Rosuvastatin Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Rosuvastatin Drugs Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Rosuvastatin Drugs Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Rosuvastatin Drugs Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Rosuvastatin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Rosuvastatin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Rosuvastatin Drugs Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Rosuvastatin Drugs Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Rosuvastatin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Rosuvastatin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Rosuvastatin Drugs Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Rosuvastatin Drugs Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Rosuvastatin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Rosuvastatin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Rosuvastatin Drugs Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Rosuvastatin Drugs Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Rosuvastatin Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Rosuvastatin Drugs Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Rosuvastatin Drugs Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Rosuvastatin Drugs Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Rosuvastatin Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Rosuvastatin Drugs Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Rosuvastatin Drugs Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Rosuvastatin Drugs Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Rosuvastatin Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Rosuvastatin Drugs Revenue by Country (2023-2028) & (US$ Million)
Table 107. AstraZeneca Corporation Information
Table 108. AstraZeneca Description and Major Businesses
Table 109. AstraZeneca Rosuvastatin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. AstraZeneca Rosuvastatin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. AstraZeneca Recent Developments
Table 112. Watson Corporation Information
Table 113. Watson Description and Major Businesses
Table 114. Watson Rosuvastatin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Watson Rosuvastatin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Watson Recent Developments
Table 117. ANGITA Corporation Information
Table 118. ANGITA Description and Major Businesses
Table 119. ANGITA Rosuvastatin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. ANGITA Rosuvastatin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. ANGITA Recent Developments
Table 122. Sun Pharmaceutical Industries Corporation Information
Table 123. Sun Pharmaceutical Industries Description and Major Businesses
Table 124. Sun Pharmaceutical Industries Rosuvastatin Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. Sun Pharmaceutical Industries Rosuvastatin Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Sun Pharmaceutical Industries Recent Developments
Table 127. Key Raw Materials Lists
Table 128. Raw Materials Key Suppliers Lists
Table 129. Rosuvastatin Drugs Distributors List
Table 130. Rosuvastatin Drugs Customers List
Table 131. Rosuvastatin Drugs Market Trends
Table 132. Rosuvastatin Drugs Market Drivers
Table 133. Rosuvastatin Drugs Market Challenges
Table 134. Rosuvastatin Drugs Market Restraints
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
List of Figures
Figure 1. Rosuvastatin Drugs Product Picture
Figure 3. Global Rosuvastatin Drugs Market Share by Type in 2021 & 2028
Figure 3. 5 mg Tablet Product Picture
Figure 4. 10 mg Tablet Product Picture
Figure 5. 20 mg Tablet Product Picture
Figure 6. 40 mg Tablet Product Picture
Figure 7. Global Rosuvastatin Drugs Market Share by Application in 2021 & 2028
Figure 8. Hyperlipidemia And Mixed Dyslipidemia
Figure 9. Familial Hypercholesterolemia
Figure 10. Hypertriglyceridemia
Figure 11. Primary Dysbetalipoproteinemia (Type III Hyperlipoproteinemia)
Figure 12. Atherosclerosis
Figure 13. Others
Figure 14. Rosuvastatin Drugs Report Years Considered
Figure 15. Global Rosuvastatin Drugs Sales 2017-2028 (K Units)
Figure 16. Global Rosuvastatin Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 17. Global Rosuvastatin Drugs Revenue 2017-2028 (US$ Million)
Figure 18. Global Rosuvastatin Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 19. Global Rosuvastatin Drugs Sales Market Share by Region (2017-2022)
Figure 20. Global Rosuvastatin Drugs Sales Market Share by Region (2023-2028)
Figure 21. North America Rosuvastatin Drugs Sales YoY (2017-2028) & (K Units)
Figure 22. North America Rosuvastatin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Europe Rosuvastatin Drugs Sales YoY (2017-2028) & (K Units)
Figure 24. Europe Rosuvastatin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Asia-Pacific Rosuvastatin Drugs Sales YoY (2017-2028) & (K Units)
Figure 26. Asia-Pacific Rosuvastatin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Latin America Rosuvastatin Drugs Sales YoY (2017-2028) & (K Units)
Figure 28. Latin America Rosuvastatin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 29. Middle East & Africa Rosuvastatin Drugs Sales YoY (2017-2028) & (K Units)
Figure 30. Middle East & Africa Rosuvastatin Drugs Revenue YoY (2017-2028) & (US$ Million)
Figure 31. The Rosuvastatin Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 32. The Top 5 and 10 Largest Manufacturers of Rosuvastatin Drugs in the World: Market Share by Rosuvastatin Drugs Revenue in 2021
Figure 33. Global Rosuvastatin Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 34. Global Rosuvastatin Drugs Sales Market Share by Type (2017-2028)
Figure 35. Global Rosuvastatin Drugs Revenue Market Share by Type (2017-2028)
Figure 36. Global Rosuvastatin Drugs Sales Market Share by Application (2017-2028)
Figure 37. Global Rosuvastatin Drugs Revenue Market Share by Application (2017-2028)
Figure 38. North America Rosuvastatin Drugs Sales Market Share by Type (2017-2028)
Figure 39. North America Rosuvastatin Drugs Revenue Market Share by Type (2017-2028)
Figure 40. North America Rosuvastatin Drugs Sales Market Share by Application (2017-2028)
Figure 41. North America Rosuvastatin Drugs Revenue Market Share by Application (2017-2028)
Figure 42. North America Rosuvastatin Drugs Sales Share by Country (2017-2028)
Figure 43. North America Rosuvastatin Drugs Revenue Share by Country (2017-2028)
Figure 44. U.S. Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 45. Canada Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 46. Europe Rosuvastatin Drugs Sales Market Share by Type (2017-2028)
Figure 47. Europe Rosuvastatin Drugs Revenue Market Share by Type (2017-2028)
Figure 48. Europe Rosuvastatin Drugs Sales Market Share by Application (2017-2028)
Figure 49. Europe Rosuvastatin Drugs Revenue Market Share by Application (2017-2028)
Figure 50. Europe Rosuvastatin Drugs Sales Share by Country (2017-2028)
Figure 51. Europe Rosuvastatin Drugs Revenue Share by Country (2017-2028)
Figure 52. Germany Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 53. France Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 54. U.K. Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 55. Italy Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 56. Russia Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 57. Asia Pacific Rosuvastatin Drugs Sales Market Share by Type (2017-2028)
Figure 58. Asia Pacific Rosuvastatin Drugs Revenue Market Share by Type (2017-2028)
Figure 59. Asia Pacific Rosuvastatin Drugs Sales Market Share by Application (2017-2028)
Figure 60. Asia Pacific Rosuvastatin Drugs Revenue Market Share by Application (2017-2028)
Figure 61. Asia Pacific Rosuvastatin Drugs Sales Share by Region (2017-2028)
Figure 62. Asia Pacific Rosuvastatin Drugs Revenue Share by Region (2017-2028)
Figure 63. China Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 64. Japan Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 65. South Korea Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 66. India Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 67. Australia Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 68. Taiwan Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 69. Indonesia Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 70. Thailand Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 71. Malaysia Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 72. Philippines Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 73. Latin America Rosuvastatin Drugs Sales Market Share by Type (2017-2028)
Figure 74. Latin America Rosuvastatin Drugs Revenue Market Share by Type (2017-2028)
Figure 75. Latin America Rosuvastatin Drugs Sales Market Share by Application (2017-2028)
Figure 76. Latin America Rosuvastatin Drugs Revenue Market Share by Application (2017-2028)
Figure 77. Latin America Rosuvastatin Drugs Sales Share by Country (2017-2028)
Figure 78. Latin America Rosuvastatin Drugs Revenue Share by Country (2017-2028)
Figure 79. Mexico Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 80. Brazil Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 81. Argentina Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 82. Middle East and Africa Rosuvastatin Drugs Sales Market Share by Type (2017-2028)
Figure 83. Middle East and Africa Rosuvastatin Drugs Revenue Market Share by Type (2017-2028)
Figure 84. Middle East and Africa Rosuvastatin Drugs Sales Market Share by Application (2017-2028)
Figure 85. Middle East and Africa Rosuvastatin Drugs Revenue Market Share by Application (2017-2028)
Figure 86. Middle East and Africa Rosuvastatin Drugs Sales Share by Country (2017-2028)
Figure 87. Middle East and Africa Rosuvastatin Drugs Revenue Share by Country (2017-2028)
Figure 88. Turkey Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 89. Saudi Arabia Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 90. UAE Rosuvastatin Drugs Revenue (2017-2028) & (US$ Million)
Figure 91. Rosuvastatin Drugs Value Chain
Figure 92. Rosuvastatin Drugs Production Process
Figure 93. Channels of Distribution
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount